We’ve recently updated our valuation analysis.

Terveystalo Oyj Valuation

Is TTALO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for TTALO?

Other financial metrics that can be useful for relative valuation.

TTALO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.3x
Enterprise Value/EBITDA15x
PEG Ratio4.5x

Price to Earnings Ratio vs Peers

How does TTALO's PE Ratio compare to its peers?

The above table shows the PE ratio for TTALO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average44.1x
PIHLIS Pihlajalinna Oyj
22.1x22.5%€214.3m
REG1V Revenio Group Oyj
39.3x18.7%€834.4m
OKDBV Oriola Oyj
65.9x34.6%€256.2m
HLS Healius
49.4x42.3%AU$1.8b
TTALO Terveystalo Oyj
101.5x22.6%€1.0b

Price-To-Earnings vs Peers: TTALO is expensive based on its Price-To-Earnings Ratio (101.5x) compared to the peer average (44.1x).


Price to Earnings Ratio vs Industry

How does TTALO's PE Ratio compare vs other companies in the European Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a19.1%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a19.1%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: TTALO is expensive based on its Price-To-Earnings Ratio (101.5x) compared to the European Healthcare industry average (19.6x)


Price to Earnings Ratio vs Fair Ratio

What is TTALO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TTALO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio101.5x
Fair PE Ratio43.6x

Price-To-Earnings vs Fair Ratio: TTALO is expensive based on its Price-To-Earnings Ratio (101.5x) compared to the estimated Fair Price-To-Earnings Ratio (43.6x).


Share Price vs Fair Value

What is the Fair Price of TTALO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: TTALO (€8.18) is trading below our estimate of fair value (€16.85)

Significantly Below Fair Value: TTALO is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst TTALO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€8.07
€9.68
+20.0%
9.3%€11.00€8.40n/a5
May ’24€7.93
€9.30
+17.3%
11.2%€11.00€8.30n/a5
Apr ’24€7.02
€9.30
+32.5%
11.2%€11.00€8.30n/a5
Mar ’24€7.15
€9.30
+30.1%
11.2%€11.00€8.30n/a5
Feb ’24€7.19
€9.04
+25.7%
15.8%€11.00€7.30n/a5
Jan ’24€6.25
€8.59
+37.4%
18.2%€11.00€7.25n/a5
Dec ’23€6.41
€8.59
+34.0%
18.2%€11.00€7.25n/a5
Nov ’23€6.15
€8.59
+39.7%
18.2%€11.00€7.25n/a5
Oct ’23€8.27
€10.95
+32.4%
9.9%€13.00€9.90n/a5
Sep ’23€8.82
€10.95
+24.1%
9.9%€13.00€9.90n/a5
Aug ’23€9.27
€10.95
+18.1%
9.9%€13.00€9.90n/a5
Jul ’23€10.28
€13.02
+26.7%
6.1%€14.20€11.90n/a5
Jun ’23€10.42
€13.02
+25.0%
6.1%€14.20€11.90n/a5
May ’23€10.70
€13.02
+21.7%
6.1%€14.20€11.90€7.935
Apr ’23€11.28
€13.18
+16.8%
5.7%€14.20€11.90€7.025
Mar ’23€10.68
€13.18
+23.4%
5.7%€14.20€11.90€7.155
Feb ’23€11.64
€13.24
+13.7%
5.7%€14.00€11.90€7.195
Jan ’23€11.84
€13.24
+11.8%
5.7%€14.00€11.90€6.255
Dec ’22€11.00
€13.24
+20.4%
5.7%€14.00€11.90€6.415
Nov ’22€11.20
€13.24
+18.2%
5.7%€14.00€11.90€6.155
Oct ’22€10.92
€13.24
+21.2%
5.7%€14.00€11.90€8.275
Sep ’22€12.38
€13.24
+6.9%
5.7%€14.00€11.90€8.825
Aug ’22€11.46
€13.04
+13.8%
5.2%€14.00€11.90€9.275
Jul ’22€11.48
€13.04
+13.6%
5.2%€14.00€11.90€10.285
Jun ’22€11.88
€12.27
+3.3%
11.3%€13.50€9.70€10.426
May ’22€11.90
€12.27
+3.1%
11.3%€13.50€9.70€10.706

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies